Evidence map›Paper›PMID 30299561›Full record

ArticleHepatology (Baltimore, Md.)2019

The Chemosensory Function of Primary Cilia Regulates Cholangiocyte Migration, Invasion, and Tumor Growth.

Adrian P Mansini, Estanislao Peixoto, Sujeong Jin, Seth Richard, Sergio A Gradilone

Abstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Cholangiocytes' primary cilia regulate DNA damage response and repair.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  4. Review
  5. The Primary Cilia are Associated with the Axon Initial Segment in Neurons.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Neuronal guidance behaviours: the primary cilium perspective.Frontiers in cell and developmental biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Clinical and genetic heterogeneity of primary ciliopathies (Review).International journal of molecular medicine · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Adrian P MansiniThe Hormel Institute, University of Minnesota, Austin, MN.
Estanislao PeixotoThe Hormel Institute, University of Minnesota, Austin, MN.
Sujeong JinThe Hormel Institute, University of Minnesota, Austin, MN.
Seth RichardThe Hormel Institute, University of Minnesota, Austin, MN.
Sergio A GradiloneThe Hormel Institute, University of Minnesota, Austin, MN.
University of Minnesota · USHormel (United States) · US

Funding

The Cholangiocyte Primary Cilium as a Tumor Suppressor OrganelleR01CA183764 · NCI · UNIVERSITY OF MINNESOTA · PI GRADILONE, SERGIO A · 2015 to 2019
$1.7M
Hormel FoundationNCI NIH HHS R01 CA183764Randy Shaver Cancer Research and Community Fund
6 · The paper itself

Abstract

Cholangiocytes, the epithelial cells lining the biliary tree in the liver, express primary cilia that can detect several kinds of environmental signals and then transmit this information into the cell. We have reported that cilia are significantly reduced in cholangiocarcinoma (CCA) and that the experimental deciliation of normal cells induces a malignant-like phenotype with increased proliferation, anchorage-independent growth, invasion, and migration. Here, we tested the hypothesis that the chemosensory function of cholangiocyte primary cilia acts as a mechanism for tumor suppression. We found that in the presence of extracellular nucleotides cilia-dependent chemosensation of the nucleotides inhibited migration and invasion in normal ciliated cholangiocytes through a P2Y11 receptor and liver kinase B1 (LKB1)-phosphatase and tensin homolog-AKT-dependent mechanism. In contrast, in normal deciliated cholangiocytes and CCA cells, the nucleotides induced the opposite effects, i.e., increased migration and invasion. As activation of LKB1 through a cilia-dependent mechanism was required for the nucleotide-mediated inhibitory effects on migration and invasion, we attempted to activate LKB1 directly, independent of ciliary expression, using the compound hesperidin methyl chalcone (HMC). We found that HMC induced activation of LKB1 in both ciliated and deciliated cells in vitro, resulting in the inhibition of migration and proliferation. Furthermore, using a rat syngeneic orthotopic CCA model, we found that HMC inhibited tumor growth in vivo. Conclusion: These findings highlight the importance of the chemosensory function of primary cilia for the control of migration and invasion and suggest that, by directly activating LKB1 and bypassing the need for primary cilia, it is possible to emulate this chemosensory function in CCA cells; these data warrant further studies evaluating the possibility of using HMC as therapy for CCA.

Indexed as

Adenosine TriphosphateAdenylyl CyclasesAMP-Activated Protein Kinase KinasesAnimalsBile Duct NeoplasmsCell Line, TumorCell MovementChemoreceptor CellsCholangiocarcinomaCiliaCyclic AMP-Dependent Protein KinasesHumansProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseRatsAdenosine TriphosphateAdenylyl Cyclasesadenylyl cyclase type VAMP-Activated Protein Kinase KinasesCyclic AMP-Dependent Protein KinasesP2RY11 protein, humanProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseReceptors, Purinergic P2STK11 protein, human

Identifiers

PMID30299561
PMCPMC6438749
OpenAlexW2897969516

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.